M2 Macrophage Therapy
Graft‑Versus‑Host Disease (GVHD)
Phase 1Active
Key Facts
About Cytopeutics
MSC‑based cell therapy platform with halal‑certified products for Asia‑Pacific clinical markets.
View full company profileGraft‑Versus‑Host Disease (GVHD)
MSC‑based cell therapy platform with halal‑certified products for Asia‑Pacific clinical markets.
View full company profile